EJCTS Click here to locate an Ethicon representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barendregt, W. B.
Right arrow Articles by Janssen, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barendregt, W. B.
Right arrow Articles by Janssen, J. P.

European Journal of Cardio-Thoracic Surgery, Vol 9, 655-658, Copyright © 1995 by European Association for Cardio-thoracic Surgery


ARTICLES

The value of parasternal mediastinoscopy in staging bronchial carcinoma

WB Barendregt, HW Deleu, HJ Joosten, W Berg and JP Janssen
Department of General Surgery, Canisius Wilhelmina Hospital, Nijmegen, Netherlands.

Computed tomography (CT) is the non-invasive staging procedure of choice for assessment of metastasis to mediastinal lymph nodes in patients with bronchial carcinoma. Cervical mediastinoscopy can provide histologic evidence of mediastinal spread to the peritracheal, tracheobronchial and subcarinal lymph nodes. Sub-aortic and para-aortic nodes cannot be sampled via this route. The present study was performed to assess the staging value of the parasternal mediastinoscopy as a separate entity. Cervical and parasternal mediastinoscopy was performed in 37 patients with a proven diagnosis of non-small cell carcinoma of the left upper lobe. In 16 patients lymph node or tumor tissue could be biopsied via the parasternal route, in 21 patients no parasternal biopsy was taken. Of the 16 cases with biopsies, only one was positive (6%). Histologic examination of lymph node biopsy tissue was false negative in one other patient (6%). Of the 21 patients without biopsies taken during parasternal mediastinoscopy, three (14%) had proven lymphogenic spread to the subaortic and para-aortic nodes, detected at thoracotomy. The parasternal procedure changed treatment in only one patient (3%). Diagnostic sensitivity was 20%. It is concluded that parasternal mediastinoscopy should not be used as a routine staging procedure in patients with left upper lobe lung cancer.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
J. Mouroux, N. Venissac, and M. Alifano
Combined video-assisted mediastinoscopy and video-assisted thoracoscopy in the management of lung cancer
Ann. Thorac. Surg., November 1, 2001; 72(5): 1698 - 1704.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Fritscher-Ravens, N. Soehendra, L. Schirrow, P. V. J. Sriram, A. Meyer, H.-P. Hauber, and A. Pforte
Role of Transesophageal Endosonography-Guided Fine-Needle Aspiration in the Diagnosis of Lung Cancer
Chest, February 1, 2000; 117(2): 339 - 345.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.